Connect with:
Tuesday / November 19. 2024

logo
mobile-logo
HomePosts Tagged "DCM Shriram Limited"
Agro Universities, Foodgrains, R&D, Seeds

The partnership extension will advance research initiatives that aim to develop improved rice varieties with multiple tolerances for biotic and abiotic stresses.

Bioseed and the International Rice Research Institute (IRRI) recently agreed to an amendment of their Memorandum of Understanding (MOU) which will extend their ongoing partnership for a further five years, advancing research initiatives that aim to develop improved rice varieties with multiple tolerances for biotic and abiotic stresses. The amendment will extend the partnership for a further five (5) years, from May 2022 to April 2027.

A seed and biotechnology company, Bioseed is a wholly owned subsidiary of DCM Shriram Limited, one of India’s largest agricultural conglomerates. Bioseed’s partnership with IRRI is through IRRI’s Bio-Innovation Center (BIC), a membership-based program that enables public and private sector partners to leverage the institute’s world-class research infrastructure, expertise, and resources for the development or scaling up of their own products or research solutions. Bioseed has been a BIC member since August 2020.

Bioseed and IRRI have several collaborative projects currently ongoing. These include:  Evaluation of transgenic maize events for resistance to fall armyworm; Evaluation of transgenic events of rice for drought and salinity tolerance and introgression of selected events in the elite parental lines of Bioseed Research Philippines Inc. rice hybrids; Gene editing rice for improved grain yield, drought tolerance, and leaf blight and blast resistance; Development, characterization, and evaluation of transgenic lines of rice for drought and salt tolerance and enhanced nitrogen assimilation; and Transgenic rice events evaluation for drought tolerance, nutrient utilization, and yield improvement.

 Signatories of the amendment were Dr Ajay Kohli, Interim Director General of IRRI, and Dr Paresh Verma, Chief Executive and Research Director of Bioseed SE Asia. Witnessing the signing were Dr. Gururaj Kulkarni, IRRI Bio-Innovation Center Director, and Devadatta Sirdeshpande, Executive President and General Manager of Bioseed Research Philippines.

The partnership extension will advance research initiatives

Agribusiness, Agro chems – Chemicals, Company News, Finance, India, Sugar industry

The company has reported total income of Rs 2555.23 crores during the period ended March 31, 2024, as compared to Rs 2874.44 crores during the period ended March 31, 2023.

DCM Shriram Limited has reported Consolidated financial results for the period ended March 31, 2024. The company has reported total income of Rs 2555.23 crores during the period ended March 31, 2024, as compared to Rs. 3172.65 crores during the period ended December 31, 2023. The company has posted net profit / (loss) of Rs 117.80 crores for the period ended March 31, 2024, as against net profit / (loss) of Rs. 240.48 crores for the period ended December 31, 2023.The company has reported EPS of Rs 7.55 for the period ended March 31, 2024, as compared to Rs. 15.42 for the period ended December 31, 2023.

The company has reported total income of Rs. 2555.23 crores during the period ended March 31, 2024, as compared to Rs.2874.44 crores during the period ended March 31, 2023. The company has posted net profit / (loss) of Rs.117.80 crores for the period ended March 31, 2024, as against net profit / (loss) of Rs186.67 crores for the period ended March 31, 2023.The company has reported EPS of Rs.7.55 for the period ended March 31, 2024, as compared to Rs.11.97 for the period ended March 31, 2023.

The company has reported total income of Rs.11529.83 crores during the Financial Year ended March 31, 2024, as compared to Rs 12199.19 crores during the Financial Year ended March 31, 2023. The company has posted net profit / (loss) of Rs.447.10 crores for the Financial Year ended March 31, 2024, as against net profit / (loss) of Rs.910.84 crores for the Financial Year ended March 31, 2023.

The company has reported total income of